🇺🇸 FDA

Drug profile · INN

alendronate sodium

ALENDRONATE SODIUM

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

alendronate sodium (ALENDRONATE SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN alendronate sodium
Brand ALENDRONATE SODIUM
Route ORAL
Formulation TABLET, EFFERVESCENT
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 6696601

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6281381

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is alendronate sodium?

alendronate sodium (ALENDRONATE SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for alendronate sodium?

ALENDRONATE SODIUM is a marketed brand name for alendronate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of alendronate sodium?

alendronate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.